Marshall Wace Asia’s New Frontier Health Corporation Ordinary Shares NFH Stock Holding History

Marshall Wace Asia’s Portfolio NFH Stock Details NFH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q3	$254K	Buy	+22,652	New	+$253K	0.01%	114

Other funds holding NFH

Vivo Capital Palo Alto, California $1.1B AUM 799.93% 1-Year Est. Return

Fosun International Hong Kong, China $446M AUM 13.33% 1-Year Est. Return

Nan Fung Group Holdings Kai Tak, Hong Kong $131M AUM 86.64% 1-Year Est. Return

Capital Research Global Investors

Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return

Oasis Management Company Grand Cayman, Cayman Islands $1.88B AUM 54.21% 1-Year Est. Return

York Capital Management Global Advisors New York $87.8M AUM 45.55% 1-Year Est. Return

Aspex Management (HK) Central, Hong Kong $8.89B AUM 39.91% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

BlueCrest Capital Management St Helier, Jersey $3.04B AUM 26.78% 1-Year Est. Return

Maso Capital Partners Hong Kong $60.9M AUM 0.32% 1-Year Est. Return

Marshall Wace Asia's NFH Position: Q3 2021 in Review

Marshall Wace Asia opened a new position in New Frontier Health Corporation Ordinary Shares (NFH) in Q3 2021: 22,652 shares worth $254K. The stake represents 0.01% of the portfolio and ranks #114 among its holdings.

49 funds tracked by Wall St. Rank hold NFH as of Q3 2021.

Marshall Wace Asia held 22,652 shares of New Frontier Health Corporation Ordinary Shares worth $254K as of Q3 2021.
New Frontier Health Corporation Ordinary Shares was a new Marshall Wace Asia position in Q3 2021.
New Frontier Health Corporation Ordinary Shares made up 0.01% of Marshall Wace Asia's portfolio in Q3 2021, its #114 holding.
49 funds tracked by Wall St. Rank held New Frontier Health Corporation Ordinary Shares as of Q3 2021.

Based on Marshall Wace Asia's 13F filing for Q3 2021, filed 15 Nov 2021.